Clinical Trial Update: Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tigerase® to Pulmozyme® in cystic fibrosis patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Pulmozyme (dornase alfa)
• Tigerase®

Snippet

Sponsor: AO GENERIUM | Conditions: Cystic Fibrosis, Fibrosis | Phase 3 | Status: COMPLETED